slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,131-5,160
Pages 350
Rows per page 30
Slide type
5,131-5,160 of 10,471
11
The slide uses a split-screen layout with quantitative metrics on the left and a qualitative testimonial on the right.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · Traction1 hit
12
23andMe | Investor Presentation Deck | 57 slides23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · Traction1 hit
29
The slide uses a table for disease phenotypes and a vertical timeline for the COVID-19 study milestones.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
31
The left side shows Manhattan plots for Osteoarthritis over time (2016, 2017, 2021). The right side shows a line chart of total independent hits from 2015 to 2020.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
15
The diagram is a circular flywheel process showing the integration of data, wet lab validation, and AI creation.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
21
The slide uses a table-like layout to present key company metrics as evidence of market readiness.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
03
The slide uses a list-based structure to categorize updates into clinical programs and corporate status.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
11
The chart displays efficacy data for a drug candidate, noting the impact of anti-drug antibodies (ADAs) on the third cohort.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
17
The slide presents two distinct clinical metrics: a box plot for arginine levels and a bar chart for patient response rates.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
18
Clinical trial data presentation with statistical significance markers and MCID thresholds.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
19
The slide uses a heatmap to visualize individual patient outcomes, highlighting clinical improvement vs. worsening.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
28
Includes histological images of liver tissue and a dot plot for bone mineral density (BMD).Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
31
Box plot visualization of clinical trial results.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
32
Includes both continuous mean change data and categorical responder analysis.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
33
Includes a study design timeline and MCID reference lines for GMFCS levels.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
36
The table highlights specific clinical response metrics for six individual patients, demonstrating improvements and normalization of mobility scores.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
08
Slide presents a press release excerpt as evidence of commercial/government traction.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
51
The chart includes a dashed yellow trend line starting from Dec-21 to emphasize the recent acceleration in growth.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
52
The slide uses a high-impact, minimal text approach to demonstrate technical achievement.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
09
Includes a quote from Keith Nuechterlein, Ph.D. regarding the clinical significance of the Symbol Coding results.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a vertical process flow to show the progression of clinical trials and data validation.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
11
The slide highlights the 'inverted-U' dose-response curve, a key pharmacological characteristic for this drug candidate.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
12
The slide highlights that lower doses of RL-007 (40 or 80 mg TID) show statistically significant improvements compared to placebo in cognitive endpoints.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
17
The slide uses a numbered list to highlight key safety findings alongside a detailed data table.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
18
The slide uses topographical brain maps to visualize EEG data changes.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
23
The slide uses a line chart to show MADRS score changes over 12 weeks across three dosage groups.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
12
The chart uses a stacked bar approach to show total vs new learners, with trend arrows indicating growth velocity.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations 1 hit
15
The slide uses a timeline-based visual to demonstrate product portfolio growth, with empty circles representing future capacity.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations 1 hit
16
The slide uses a logo-grid layout to demonstrate the breadth of institutional partnerships across six key academic domains.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations 1 hit